Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?

Iman F. Montasser; Mohamed A. Sakr; Hany M. Dabbous; Kareem Abdelaziz; Hend Ebada; Yasmine M. Massoud; Mohamed Bahaa; Hany Said; Kamal Mamdouh; Mahmoud S. El Meteini

doi:10.1097/01.elx.0000546496.60509.bf

Q2 2018

Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?

Iman F. Montasser · Mohamed A. Sakr · Hany M. Dabbous · Kareem Abdelaziz · Hend Ebada · Yasmine M. Massoud · Mohamed Bahaa · Hany Said · Kamal Mamdouh · Mahmoud S. El Meteini

10.1097/01.elx.0000546496.60509.bf 388 المشاهدات 0 الاقتباسات

الاقتباسات

388

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Iman, F. M., Mohamed, A. S., Hany, M. D., Kareem, A., Hend, E., Yasmine, M. M., Mohamed, B., Hany, S., Kamal, M., Mahmoud, S. E. M. (2018). Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000546496.60509.bf

Gamal Shiha; Seham Seif; Maha Maher; Shahera Etreby; Waleed Samir; Khaled Zalata · 2014

استشهاد

389

Tissue microarray as a research tool to study non-neoplastic liver diseases

Mohamed H. Abdel-Rahman; Ahmad A. Agour; Dina S. El-Azab · 2014

استشهاد

388

Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt

Iman I. Sarhan; Cherry R. Kamel · 2015

استشهاد

391

Prevention of paracentesis-induced circulatory dysfunction